PHARMASSET INC. VRUS (NASDAQ)

$ 18.97
19:10
Change: unch (unch%)
Volume: 54,506

Avg. Volume: 276690
P/E Ratio: 0
EPS (Annual): -1.70
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 21,290
Institutional Shareholders: 46.84%
Last: 18.97
Change: unch (unch%)
Prev. Close: 18.97
Open: 18.73
Day's Range: 18.60 - 19.40
52wk Range: 9.00 - 36.44
Market Value: 424,380
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: +69.13%
Total Return Last 3 Years: +87.49%
Total Return Last 5 Years: +107.17%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on VRUS
Alert me Subscribe

Pharmasset says it sold $25.9 million in stock

(NEW YORK)Clinical-stage pharmaceutical company Pharmasset Inc. said Tuesday it has sold 1.45 million shares of stock to institutional investors, raising about $25.9 million.READ MORE
Jul 15, 2008 12:22PM
Keywords: VRUS

Pharmasset chooses lead hepatitis C drug candidate

(PRINCETON, N.J.)Clinical-stage pharmaceutical company Pharmasset Inc. said Monday that it has selected PSI-7851, a preclinical drug for treatment of hepatitis C virus, as its lead candidate for tr...READ MORE
May 19, 2008 8:00AM
Keywords: VRUS

Pharmasset shares up; analysts upbeat on hepatitis candidate

(NEW YORK)Shares of clinical-stage pharmaceutical company Pharmasset Inc. rose Friday after analysts expressed optimism about the company's hepatitis Cdrug candidate in partnership with ...READ MORE
May 16, 2008 5:15PM
Keywords: VRUS

Movers roundup: Melco, Pharmasset

Among the stock activity stories for Friday, May 16, from AP Financial News: NEW YORK (AP) _ Shares of Melco PBL Entertainment Inc. fell Friday as investors largely discounted the ...READ MORE
May 16, 2008 2:32PM
Keywords: VRUS, JMBA, ALKS, KONG, AXP, SBUX, MNT

Pharmasset hepatitis C drug meets safety goal in study

(PRINCETON, N.J.)Pharmasset Inc., a clinical-stage pharmaceutical company, said Friday its hepatitis C drug candidate R7128 met safety goals in an early-stage study. The study results were presente...READ MORE
Apr 25, 2008 2:54PM
Keywords: VRUS

Pharmasset Rises on UBS Upgrade

(NEW YORK) Shares of Pharmasset Inc. rose Wednesday, as a UBS analyst upgraded the antiviral drugmaker, citing its low share price and strong hepatitis B and C pipeline. Analyst Annabel Sam...READ MORE
Apr 02, 2008 7:57PM
Keywords: VRUS

Movers Roundup: Randgold Resources, PFF

Among the stock activity stories for Wednesday, April 2, from AP Financial News: Top stories: NEW YORK (AP) Shares of Randgold Resources Ltd. soared more than 10 percent Wednesd...READ MORE
Apr 02, 2008 2:24PM
Keywords: GOLD, PFB, CHD, MDTH, VRUS
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Sector Analysis